Proactive
GSK sells rights to rare liver disease drug for up to $690m
📈
AI Sentiment
Highly Positive
8/10
- Home
- GSK
as of 03-09-2026 3:52pm EST
$55.51
+$1.02
+1.87%
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
| Founded: | 1715 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 96.1B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 5.3M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $32.38 - $61.70 | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 6.81% | Revenue Growth (next year): | 4.74% |
| P/E Ratio: | 32.75 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | +24.02% |
Latest GSK plc (Each representing two) News
GSK Breaking Stock News: Dive into GSK Ticker-Specific Updates for Smart Investing
The Wall Street Journal
GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million
📈
AI Sentiment
Highly Positive
8/10
24/7 Wall St.
Is It Too Late to Buy GSK After a 46% Share Price Jump?
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Is It Time To Reassess GSK (LSE:GSK) After Its Strong Multi‑Year Share Price Run?
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
GSK RAPT Acquisition Adds Food Allergy Asset To Immunology Growth Story
📈
AI Sentiment
Highly Positive
8/10
MarketWatch
These 8 drugs could help fight dementia — and they’re already on the market
📊
AI Sentiment
Positive
6/10
PR Newswire
Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced Therapies Rises | DelveInsight
📈
AI Sentiment
Highly Positive
9/10
PR Newswire
Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity
📈
AI Sentiment
Highly Positive
9/10
Compare GSK vs Leading Stocks
See how GSK stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "GSK GSK plc (Each representing two) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.